NCT02305602View on ClinicalTrials.gov

A Study of VentriGel in Post-MI Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 5, 2018

Study Completion Date

June 30, 2019

Conditions
Myocardial InfarctionHeart FailureLeft Ventricular Remodeling
Interventions
BIOLOGICAL

VentriGel

VentriGel will be injected via MyoStar catheter after NOGA mapping

Trial Locations (6)

32606

University of Florida, Gainesville

55407

Minneapolis Heart Institute, Minneapolis

60612

Rush University Medical Center, Chicago

84132

University of Utah, Salt Lake City

85297

Mercy Gilbert Medical Center, Gilbert

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Ventrix, Inc.

INDUSTRY

NCT02305602 - A Study of VentriGel in Post-MI Patients | Biotech Hunter | Biotech Hunter